Ultrasound‐guided core‐needle biopsy in the diagnosis of head and neck masses: Indications, technique, and results

Abstract

Ultrasound-guided core-needle biopsies can be recommended as a safe and reliable technique in the diagnosis of cervicofacial masses with a high diagnostic yield. It obtains tissue samples of high quality and represents a sufficient alternative to open biopsy even in the diagnosis of lymphoma.

Comparison of ultrasound‐guided core‐needle biopsy and fine‐needle aspiration in the assessment of head and neck lesions

“…9,13 FNA is a simple and cost-effective method, which allows for better information for our patients and detailed planning of the operative procedure. With a good puncture technique and an experienced cytopathologist, FNA achieved a high sensitivity and specificity in most publications.…”

“…5,6 Nondiagnostic FNA was generally the main reason for study inclusion, or CNB was directly carried out without previously performing FNA. [7][8][9] This negative selection does not allow for a real comparison between these 2 techniques. In addition, the role of CNB in the work-up of head and neck masses is still unclear.…”

“…These were mainly written by interventional radiologists and reflect their experience in only a limited number of patients. [3][4][5][6][7][8][9] Most of them were retrospective studies with surgical excision performed in less than a third of all lesions. In the remaining cases, the final diagnosis was established based on clinical or laboratory findings.…”

Validity of core needle biopsy in the histopathological verification of parotid gland lesions

“…As a result of many studies (13,5,14), fine-needle biopsy is not precise enough in differentiating malignancy, so that core-biopsy is proposed as a method of choice for diagnosing large masses of maxillo-facial region.…”

Core-needly biopsy of parotid gland masses

“…2 Limfomi i metastaze skvamocelularnih karcinoma najčešći su maligniteti ove regije 3 . Pacijenti sa tumorskim masama na vratu mogu se podeliti u dve grupe, na pacijente sa već dokazanim malignitetom, kod kojih je najverovatnije u pitanju metastatski proces, kao i na pacijente koji imaju de novo nastali tumor vrata 4 .…”